These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24839226)

  • 1. Comparison of four scores to predict major bleeding in patients receiving anticoagulation for venous thromboembolism: findings from the RIETE registry.
    Piovella C; Dalla Valle F; Trujillo-Santos J; Pesavento R; López L; Font L; Valle R; Nauffal D; Monreal M; Prandoni P;
    Intern Emerg Med; 2014 Dec; 9(8):847-52. PubMed ID: 24839226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban-treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding.
    Kline JA; Jimenez D; Courtney DM; Ianus J; Cao L; Lensing AW; Prins MH; Wells PS
    Acad Emerg Med; 2016 Feb; 23(2):144-50. PubMed ID: 26765080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Bleeding Risk Scores in Elderly Patients Receiving Extended Anticoagulation with Vitamin K Antagonists for Venous Thromboembolism.
    Frei AN; Stalder O; Limacher A; Méan M; Baumgartner C; Rodondi N; Aujesky D
    Thromb Haemost; 2021 Nov; 121(11):1512-1522. PubMed ID: 33930905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: A prospective cohort study.
    Vedovati MC; Mancuso A; Pierpaoli L; Paliani U; Conti S; Ascani A; Galeotti G; Di Filippo F; Caponi C; Agnelli G; Becattini C
    Int J Cardiol; 2020 Feb; 301():167-172. PubMed ID: 31761402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism.
    Scherz N; Méan M; Limacher A; Righini M; Jaeger K; Beer HJ; Frauchiger B; Osterwalder J; Kucher N; Matter CM; Banyai M; Angelillo-Scherrer A; Lämmle B; Husmann M; Egloff M; Aschwanden M; Bounameaux H; Cornuz J; Rodondi N; Aujesky D
    J Thromb Haemost; 2013 Mar; 11(3):435-43. PubMed ID: 23279158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study.
    Guman NAM; Becking AL; Weijers SS; Kraaijpoel N; Mulder FI; Carrier M; Jara-Palomares L; Di Nisio M; Ageno W; Beyer-Westendorf J; Klok FA; Vanassche T; Otten JMMB; Cosmi B; Peters MJL; Wolde MT; Delluc A; Sanchez-Lopez V; Porreca E; Bossuyt PMM; Gerdes VEA; Büller HR; van Es N; Kamphuisen PW
    J Thromb Haemost; 2024 Sep; 22(9):2470-2481. PubMed ID: 38866248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry.
    Ruíz-Giménez N; Suárez C; González R; Nieto JA; Todolí JA; Samperiz AL; Monreal M;
    Thromb Haemost; 2008 Jul; 100(1):26-31. PubMed ID: 18612534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis in patients with cancer-associated venous thromboembolism: Comparison of the RIETE-VTE and modified Ottawa score.
    Pfaundler N; Limacher A; Stalder O; Méan M; Rodondi N; Baumgartner C; Aujesky D
    J Thromb Haemost; 2020 May; 18(5):1154-1161. PubMed ID: 32124545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism.
    Nieto JA; Solano R; Trapero Iglesias N; Ruiz-Giménez N; Fernández-Capitán C; Valero B; Tiberio G; Bura-Riviere A; Monreal M;
    Thromb Res; 2013 Aug; 132(2):175-9. PubMed ID: 23849097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Performances among Four Bleeding-Prediction Scores in Elderly Cancer Patients with Venous Thromboembolism.
    Xi S; Liu C; Yu S; Qiu J; He S; Yi Z
    Hamostaseologie; 2023 Aug; 43(4):281-288. PubMed ID: 37137330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting intracranial bleeding during anticoagulation for venous thromboembolism within different time frames: Findings from the RIETE registry.
    Maestre A; Martín Del Pozo M; Moustafa F; Chopard R; Nieto JA; Fidalgo Fernández MÁ; López Miguel P; Verhamme P; Ciammaichella MM; Monreal M;
    Thromb Res; 2024 Nov; 243():109153. PubMed ID: 39299164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
    Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
    J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry.
    Kim K; Yamashita Y; Morimoto T; Kitai T; Yamane T; Ehara N; Kinoshita M; Kaji S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Furukawa Y; Kimura T;
    Thromb Haemost; 2019 Sep; 119(9):1498-1507. PubMed ID: 31230344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the risk for major bleeding in elderly patients with venous thromboembolism using the Charlson index. Findings from the RIETE.
    Gómez-Cuervo C; Rivas A; Visonà A; Ruiz-Giménez N; Blanco-Molina Á; Cañas I; Portillo J; López-Miguel P; Flores K; Monreal M;
    J Thromb Thrombolysis; 2021 May; 51(4):1017-1025. PubMed ID: 32945982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry.
    Nieto JA; Camara T; Gonzalez-Higueras E; Ruiz-Gimenez N; Guijarro R; Marchena PJ; Monreal M;
    Thromb Haemost; 2008 Nov; 100(5):789-96. PubMed ID: 18989522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
    Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
    Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of the Kuijer score for bleeding and other adverse in-hospital events in patients with venous thromboembolism.
    Keller K; Münzel T; Hobohm L; Ostad MA
    Int J Cardiol; 2021 Apr; 329():179-184. PubMed ID: 33301828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the RIETE, Kuijer, and HAS-BLED Models to Assess 3-Month Bleeding Risk in Anticoagulated Patients Diagnosed with Venous Thromboembolic Disease.
    Ortiz Gómez S; Ruiz-Talero P; Muñoz O; Hoyos Pumarejo LM
    Clin Appl Thromb Hemost; 2024; 30():10760296241271351. PubMed ID: 39106353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulant therapy in venous thromboembolism and bleeding risk: focus on the use of predictive scores.].
    Cavagna LM; Bazzan M
    Recenti Prog Med; 2024 Sep; 115(9):389-396. PubMed ID: 39269350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding Risk Assessment in Patients with Venous Thromboembolism.
    Nopp S; Ay C
    Hamostaseologie; 2021 Aug; 41(4):267-274. PubMed ID: 33626580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.